Replicate Bioscience
A biotech company developing novel self-replicating RNA (srRNA) technology for use in infectious disease, oncology, autoimmune disease and more.
The company’s library of viral vectors, selected for driving robust and sustained protein expression and orders-of-magnitude improved performance over linear mRNA, allow for the development of treatments in applications including oncology, infectious disease, and autoimmunity.
Latest Replicate Bioscience News & Features
11 July 2023
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze